The Internet of Things Inc (TSXV: ITT) this morning announced that it has received Health Canada approval for its ThermalPass fever detection system, an impressive feat conducted in just a matter of weeks.
The approval from Health Canada came quick as a result of the product being fast-tracked under the Medical Device Establishment License (MDEL) application process, which the agency established to help fight COVID-19. The authorization allows for the interim marketing and sales of ThermalPass.
ThermalPass, designed by ITT’s AI Labs subsidiary along with Commersive Solutions, has been designed to enhance public safety by reducing the risk of spreading fever-bearing contagions, such as COVID-19. The system provides fast, touchless scanning of persons via thermal sensors at entrance-ways to high traffic and public locations, such as arenas, schools, malls, government buildings, offices, train stations and more. The use of thermal sensors, versus that of cameras, means that the device does not invade personal privacy.
The announcement of Health Canada approval follows the news from ITT that the company has seen a surge in demand for the ThermalPass system as organizations look to make their facilities safe for employees and customers alike. The approval will now enable the company to officially market and sell the product.
Internet of Things Inc last traded at $0.06 on the TSX Venture.
FULL DISCLOSURE: Internet of Things Inc is a client of Canacom Group, the parent company of The Deep Dive. The company has been compensated to cover Internet of Things Inc on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.
